Association of glycosylated hemoglobin with mortality of patients in intensive care unit: a prospective observation study

• Authors: Damera Seshi Kumar , Seema Balkrishna Wasnik , Amlendu Yadav , Rupesh Yadav

Abstracts

EN

INTRODUCTION: Glycated hemoglobin (HbA1c) is the most commonly used clinical test to estimate mean blood glucose during the past 2 to 3 months. In addition to diagnostic purposes, the HbA1c level also predicts diabetes complications. The aim of this study was to determine the association of glycosylated hemoglobin with mortality in intensive care unit (ICU). MATERIALS AND METHODS: A prospective observational study was conducted in the ICU with a total of 281 patients. These patients were classified into two groups based on their HbA1c levels: one group with HbA1c level < 6.5 % and another group with HbA1c level ≥ 6.5%. The following data were collected during the study period. Clinical details and scores such as the APACHE II score (Acute Physiology and Chronic Health Assessment) and daily SOFA (Sequential Organ Failure Assessment) scores for the period of stay in the ICU. ICU morbidities as the need for mechanical ventilation, the use of inotropes / vasopressors, the length of stay in the ICU, and the requirement of renal replacement therapy (RRT). The outcome measures were ICU mortality and 28-day mortality. RESULTS: Of 281 patients admitted to the ICU for more than 48 hours, 157 patients (55.9%) had HbA1c levels < 6.5%, with the remaining 124 (44.1%) had levels ≥ 6.5%. ICU mortality was present in 107 (38.07%) cases. ICU mortality was higher in patients in the HbA1c ≥ 6.5% group compared to the HbA1c < 6.5% group. This was statistically significant (p-value <0.001). Mortality at 28 days was observed in 125 (44.48%) cases. Patients with an HbA1c value ≥ 6.5%, there was a higher mortality at 28 days compared to patients with an HbA1c value < 6.5%. This was found to be statistically significant (p-value <0.001). CONCLUSIONS: The study showed that glycated hemoglobin levels (HbA1c) levels ≥ 6.5% had a significantly higher mortality rate compared to the patient in the HbA1c level < 6.5%.

Keywords

EN

Glycated hemoglobin; intensive care unit; mortality

• Publisher: Towarzystwo Pomocy Doraźnej
• Journal: Critical Care Innovations
• Year: 2024
• Volume: 7
• Issue: 1
• Pages: 24-33

Dates

published

2024

Contributors

author

Damera Seshi Kumar

author

Seema Balkrishna Wasnik

author

Amlendu Yadav

author

Rupesh Yadav

References

• American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020; 43(Suppl 1): S14-S31. doi: https://doi.org/10.2337/dc20-S002
• Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomark Insights. 2016; 11: 95-104. doi: https://doi.org/10.4137/BMI.S38440
• Berhe KK, Mselle LT, Gebru HB. The magnitude of chronic diabetes complications and its associated factors among diabetic patients attending the general hospitals in Tigray region, Northern Ethiopia. PLoS One. 2023; 18(8): e0290240. doi: https://doi.org/10.1371/journal.pone.0290240
• Cichosz SL, Schaarup C. Hyperglycemia as a Predictor for Adverse Outcome in ICU Patients With and Without Diabetes. J Diabetes Sci Technol. 2017; 11(6): 1272-1273. doi: https://doi.org/10.1177/1932296817721937
• Vedantam D, Poman DS, Motwani L, Asif N, Patel A, Anne KK. Stress-Induced Hyperglycemia: Consequences and Management. Cureus. 2022; 14(7): e26714. doi: https://doi.org/10.7759/cureus.26714 www.criticalcareinnovations.eu doi:10.32114/CCI.2024.7.1.24.33
• Luethi N, Cioccari L, Tanaka A, Kar P, Giersch E, Deane AM, et al.. Glycated Hemoglobin A1c Levels Are Not Affected by Critical Illness. Crit Care Med. 2016; 44(9): 1692-1694. doi: https://doi.org/10.1097/CCM.0000000000001656
• Hermanides RS, Kennedy MW, Kedhi E, van Dijk PR, Timmer JR, Ottervanger JP, et al.. Impact of elevated HbA1c on long-term mortality in patients presenting with acute myocardial infarction in daily clinical practice: insights from a 'real world' prospective registry of the Zwolle Myocardial Infarction Study Group. Eur Heart J Acute Cardiovasc Care. 2020; 9(6): 616-625. doi: https://doi.org/10.1177/2048872619849921
• Kim HJ, Shim JK, Youn YN, Song JW, Lee H, Kwak YL. Influence of preoperative hemoglobin A1c on early outcomes in patients with diabetes mellitus undergoing off-pump coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2020; 159(2): 568-576. doi: https://doi.org/10.1016/j.jtcvs.2019.01.086
• Khan K, Ahmed L, Saeed K, Alothman S, Suman P, Gray S, et al.. Improvement in glycated hemoglobin A1C after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy in an ethnically diverse population with diabetes. Surg Obes Relat Dis. 2020; 16(10): 1414-1418. doi: https://doi.org/10.1016/j.soard.2020.06.004
• Avci BS, Saler T, Avci A, Bankir M, Tuzun Z, Nazik H, et al.. Relationship Between Morbidity and Mortality and HbA1c Levels in Diabetic Patients Undergoing Major Surgery. J Coll Physicians Surg Pak. 2019; 29(11): 1043-1047. doi: https://doi.org/10.29271/jcpsp.2019.11.1043
• Gornik I, Gornik O, Gasparović V. HbA1c is outcome predictor in diabetic patients with sepsis. Diabetes Res Clin Pract. 2007; 77(1): 120-125. doi: https://doi.org/10.1016/j.diabres.2006.10.017
• Lionel KR, John J, Sen N. Glycated hemoglobin A: A predictor of outcome in trauma admissions to intensive care unit. Indian J Crit Care Med. 2014; 18(1): 21-25. doi: https://doi.org/10.4103/0972-5229.125431
• Kompoti M, Michalia M, Salma V, Diogou E, Lakoumenta A, Clouva-Molyvdas PM. Glycated hemoglobin at admission in the intensive care unit: clinical implications and prognostic relevance. J Crit Care. 2015; 30(1): 150-155. doi: https://doi.org/10.1016/j.jcrc.2014.08.014
• Alghamdi AS, Alqadi A, Jenkins RO, Haris PI. The Influence of Gender and Menopausal Status on Hba1c Variation in a Big Data Study of a Saudi Population. Curr Diabetes Rev. 2021; 17(3): 365-372. doi: https://doi.org/10.2174/1573399816999200729143238
• Mahmoodpoor A, Hamishehkar H, Shadvar K, Beigmohammadi M, Iranpour A, Sanaie S. Relationship between glycated hemoglobin, Intensive Care Unit admission blood sugar and glucose control with ICU mortality in critically ill patients. Indian J Crit Care Med. 2016; 20(2): 67-71. doi: https://doi.org/10.4103/0972-5229.175938
• Farah R, Makhoul N, Samohvalov A, Nseir W. Plasma Glycated Hemoglobin A1c Could Predict 30-Day Allcause Mortality of Intensive Care Unit Patients with Hyperglycemia. Isr Med Assoc J. 2022; 24(11): 708-712.
• Podder V, Srivastava V, Kumar S, Nagarathna R, Sivapuram MS, Kaur N, et al.. Prevalence and Awareness of Stroke and Other Comorbidities Associated with Diabetes in Northwest India. J Neurosci Rural Pract. 2020; 11(3): 467-473. doi: https://doi.org/10.1055/s-0040-1709369
• Lee YS, Min KH, Lee SY, Shim JJ, Kang KH, Cho WH, et al.. The value of glycated hemoglobin as predictor of organ dysfunction in patients with sepsis. PLoS One. 2019; 14(5): e0216397. doi: https://doi.org/10.1371/journal.pone.0216397

Identifiers

DOI

10.32114/CCI.2024.7.1.24.33

Biblioteka Nauki

29432036